HealthAssure
HealthAssureGood Life
LOINCActiveObservation

LOINC Code 88862-8: Hematopoietic stem cell transplantation risk score interpretation EBMT

88862-8 is a LOINC code used to identify Hematopoietic stem cell transplantation risk score interpretation EBMT in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Hematopoietic stem cell transplantation risk score interpretation. It is commonly used with the system or sample type ^Patient.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Hematopoietic stem cell transplantation risk score interpretation. It is commonly used with the system or sample type ^Patient.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Observation
  • Method: EBMT

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

Hematopoietic stem cell transplantation risk score interpretation EBMT
Hematopoietic stem cell transplantation risk score interpretation
This term represents the European Group for Blood and Marrow Transplantation (EBMT) cumulative hematopoietic stem cell transplantation (HSCT) risk score interpretation based on the following factorsthe age of the patient, the stage of disease, the time from diagnosis, the donor type, and the donor recipient gender combination. The scores for the individual factors are added together to determine the overall likelihood of success of an HSCT. One study used the EBMT score interpretations and found the following 5-year survival rates: low risk patients had a 50% 5-year survival rate; intermediate risk patients had a 41% 5-year survival rate; poor risk patients had a 31% 5-year survival rate.[http://www.bloodjournal.org/content/126/23/3223]
CLIN; CLIN.RISK; HSCT risk score; HSCT risk score interp; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Hematopoietic stem cell transplantation risk score interpretation EBMTHSCT risk score interp EBMTHematopoietic stem cell transplantation risk score interpretationCLIN.RISKImpPt^Patient

Frequently asked questions

Code details

Code88862-8
SystemLOINC
Display nameHematopoietic stem cell transplantation risk score interpretation EBMT
DescriptionHematopoietic stem cell transplantation risk score interpretation
Short nameHSCT risk score interp EBMT
ComponentHematopoietic stem cell transplantation risk score interpretation
PropertyImp
TimingPt
System (specimen)^Patient
ScaleOrd
MethodEBMT
ClassCLIN.RISK
StatusACTIVE
Order/ObservationObservation

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.64
Last changed2.64

Part names

Hematopoietic stem cell transplantation risk score interpretationImpPt^PatientOrdEBMTImpression/interpretation of studyPoint in time (spot)European Group for Blood and Marrow Transplantation

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.